Evidence map›Paper›PMID 38533083›Full record

ArticleHeliyon2024

Improving

Clement Shiluli, Shwetha Kamath, Bernard N Kanoi, Racheal Kimani, Michael Maina, Harrison Waweru, Moses Kamita, Ibrahim Ndirangu, Hussein M Abkallo, Bernard Oduor and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. ImprovingHeliyon · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Clement ShiluliCentre for Research in Infectious Diseases, College of Graduate Studies and Research, Mount Kenya University, Thika, Kenya.
Shwetha KamathDivision of Research and Development, Jigsaw Bio Solutions Private Limited, Bangalore, India.
Bernard N KanoiCentre for Research in Infectious Diseases, College of Graduate Studies and Research, Mount Kenya University, Thika, Kenya.
Racheal KimaniCentre for Research in Infectious Diseases, College of Graduate Studies and Research, Mount Kenya University, Thika, Kenya.
Michael MainaCentre for Research in Infectious Diseases, College of Graduate Studies and Research, Mount Kenya University, Thika, Kenya.
Harrison WaweruCentre for Research in Infectious Diseases, College of Graduate Studies and Research, Mount Kenya University, Thika, Kenya.
Moses KamitaCentre for Research in Infectious Diseases, College of Graduate Studies and Research, Mount Kenya University, Thika, Kenya.
Ibrahim NdiranguCentre for Research in Infectious Diseases, College of Graduate Studies and Research, Mount Kenya University, Thika, Kenya.
Hussein M AbkalloAnimal and Human Health Program, International Livestock Research Institute, Nairobi, Kenya.
Bernard OduorAnimal and Human Health Program, International Livestock Research Institute, Nairobi, Kenya.
Nicole PammeDepartment of Materials and Environmental Chemistry, Stockholm University, Sweden.
Joshua DupatyDepartment of Biomedical Engineering, Boston University, Boston, MA, USA.
Catherine M KlapperichDepartment of Biomedical Engineering, Boston University, Boston, MA, USA.
Srinivasa Raju LolabattuDivision of Research and Development, Jigsaw Bio Solutions Private Limited, Bangalore, India.
Jesse GitakaCentre for Research in Infectious Diseases, College of Graduate Studies and Research, Mount Kenya University, Thika, Kenya.
Mount Kenya University · KEBoston University · USInternational Livestock Research Institute · KEStockholm University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Curable sexually transmitted infections (STIs), such as Methods: We identified new diagnostic target biomarker regions for Results: Our newly developed Conclusion: Therefore, there is a potential to implement this concept within miniaturized, isothermal, microfluidic platforms, and laboratory-on-a-chip diagnostic devices for highly reliable point-of-care testing.

Indexed as

Identical multirepeat sequencesIsothermalNeisseria gonorrhoeae

Identifiers

PMID38533083
PMCPMC10963193
OpenAlexW4392454397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.